Ajanta Pharma Limited — Dapagliflozin Exporter Profile
Indian Pharmaceutical Exporter · #1 for Dapagliflozin · $5.2M export value · DGFT Verified
Ajanta Pharma Limited is the #1 Indian exporter of Dapagliflozin with $5.2M in export value and 103 verified shipments. Ajanta Pharma Limited holds a 10.4% market share in Dapagliflozin exports across 4 countries. The company exports 37 pharmaceutical products worth $116.1M across 17 therapeutic categories.
Ajanta Pharma Limited — Dapagliflozin Export Profile: Buyers & Destinations
Where Does Ajanta Pharma Limited Export Dapagliflozin?
Ajanta Pharma Limited exports Dapagliflozin to 4 countries. The largest destination is IRAQ accounting for 86.1% of Ajanta Pharma Limited's Dapagliflozin shipments, followed by FRANCE (11.7%) and TANZANIA (2.3%). These destinations reflect Ajanta Pharma Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Dapagliflozin from Ajanta Pharma Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| AWAMEDICA | IRAQ | $2.4M | 59 |
| PLANET PHARMA SA | FRANCE | $446.3K | 21 |
| ROZ LOJISTIK ULUSLARARASI TASIMACIL | IRAQ | $350.0K | 7 |
| AWAMEDICA PESHAWA STREET | IRAQ | $340.9K | 7 |
| AYSA DENIZCILIK TIC. TUR. VE SAN. A | IRAQ | $200.0K | 4 |
| XXTRAXXHARXX (TXXLIMITED | TANZANIA | $57.8K | 2 |
| ASTRA PHARMA T LIMITED | TANZANIA | $28.5K | 1 |
| UNICORN MSJ LTD | MAURITIUS | $318 | 2 |
Ajanta Pharma Limited supplies Dapagliflozin to 8 buyers globally. The largest buyer is AWAMEDICA (IRAQ), followed by PLANET PHARMA SA (FRANCE) and ROZ LOJISTIK ULUSLARARASI TASIMACIL (IRAQ). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Dapagliflozin Export Value and How Much Does Ajanta Pharma Limited Contribute?
India exported $34.4M worth of Dapagliflozin through 5,104 shipments from 254 suppliers to 113 countries, serving 502 buyers globally. Ajanta Pharma Limited contributes $5.2M to this total, accounting for 10.4% of India's Dapagliflozin exports. Ajanta Pharma Limited ships Dapagliflozin to 4 countries through 8 buyers.
What Is the Average Shipment Value for Ajanta Pharma Limited's Dapagliflozin Exports?
Ajanta Pharma Limited's average Dapagliflozin shipment value is $50.0K per consignment, based on 103 shipments totaling $5.2M. The largest destination is IRAQ (86.1% of Ajanta Pharma Limited's Dapagliflozin exports).
How Does Ajanta Pharma Limited Compare to Other Indian Dapagliflozin Exporters?
Ajanta Pharma Limited ranks #1 among 254 Indian Dapagliflozin exporters with a 10.4% market share. The top 3 exporters are MICRO LABS LIMITED ($7.7M), AJANTA PHARMA LIMITED ($5.2M), ALEMBIC PHARMACEUTICALS LIMITED ($4.8M). Ajanta Pharma Limited processed 103 shipments to 4 destination countries.
What Dapagliflozin Formulations Does Ajanta Pharma Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| DAPAGLIFLOZIN TABLET 10 MG [BULK PACK TA | $300.0K | 6 |
| DAPAGLIFLOZIN 10 MG AND METFORMIN HYDROC | $200.0K | 4 |
| DAPAGLIFLOZIN 10 MG AND METFORMIN HYDROCHLORIDE 1000 MG EXTENDED RELEASE TABS[BULK PACK TABS]766199 TABS]EACH AS PER INVNOS | $150.0K | 3 |
| DAPAGLIFLOZIN TABLET 10 MG[BULK PACK TABS][791592 TABS]EACH FILM COATED TAB CONT:DAPAGLIFLOZIN (10 MG) COLOUR:AS PER INVNOS | $150.0K | 3 |
| DAPAGLIFLOZIN TABLET 10 MG [BULK PACK TABS][709393TABS]EACH FILM COATED TAB CONT:DAPAGLIFLOZIN (10 MG) COLOUR:AS PER INVNOS | $150.0K | 3 |
| DAPAGLIFLOZIN 10 MG AND METFORMIN HYDROCHLORIDE 1000 MG EXTENDED RELEASE TABLETS[BULK PACK TABS][741921 TABS]AS PER INVNOS | $150.0K | 3 |
| DAPAGLIFLOZIN 10 MG AND METFORMIN HYDROCHLORIDE 1000 MG EXTENDED RELEASE TABS [BULK PACK TABS][958774 TABS]AS PER INV | $150.0K | 3 |
| DAPAGLIFLOZIN 10 MG AND METFORMIN HYDROCHLORIDE 1000 MG EXTENDED RELEASE TABS[BULK PACK TAB][585000 TABS]EACH AS PER INV | $147.3K | 3 |
| DAPAGLIFLOZIN 10 MG AND METFORMIN HYDROCHLORIDE 1000 MG EXTENDED RELEASE TABLETS[BULK PACK TABS] [385000 TABS]AS PER INVNOS | $111.2K | 3 |
| DAPAGLIFLOZIN TABLET 10 MG[BULK PACK TAB | $100.0K | 2 |
Ajanta Pharma Limited exports 69 distinct Dapagliflozin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is DAPAGLIFLOZIN TABLET 10 MG [BULK PACK TA with 6 shipments worth $300.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
How Does Ajanta Pharma Limited Compare to Nearest Dapagliflozin Exporters?
Exporters ranked immediately above and below #1 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | MICRO LABS LIMITED | $7.7M | 442 | 24 | $17.3K |
| 1 | AJANTA PHARMA LIMITED ★ | $5.2M | 103 | 4 | $50.0K |
| 3 | ALEMBIC PHARMACEUTICALS LIMITED | $4.8M | 95 | 3 | $50.0K |
| 4 | INVENTIA HEALTHCARE LIMITED | $4.6M | 111 | 11 | $41.3K |
Ajanta Pharma Limited ranks #1 among 254 Indian Dapagliflozin exporters. Average shipment value of $50.0K compared to the market average of $135.5K. The closest competitors by value are MICRO LABS LIMITED and ALEMBIC PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Dapagliflozin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 1,003 | 19.7% |
| SAHAR AIR CARGO ACC (INBOM4) | 791 | 15.5% |
| DELHI AIR CARGO ACC (INDEL4) | 761 | 14.9% |
| DELHI AIR | 612 | 12.0% |
| Bombay Air | 194 | 3.8% |
| BANGALORE ACC (INBLR4) | 189 | 3.7% |
| BANGALORE AIR | 160 | 3.1% |
| NHAVA SHEVA SEA (INNSA1) | 136 | 2.7% |
What Other Advanced Diabetes Medications Products Does Ajanta Pharma Limited Export?
Ajanta Pharma Limited also exports these advanced diabetes medications products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Ajanta Pharma Limited's Dapagliflozin Exports
Ajanta Pharma's export operations are intricately linked to global trade routes, making them susceptible to geopolitical tensions. The ongoing Israel-Iran conflict has disrupted shipping lanes in the Red Sea, leading to increased freight costs and extended delivery timelines. Such disruptions pose challenges for Indian pharmaceutical exporters like Ajanta, necessitating adaptive logistics strategies to maintain supply chain integrity. (pharmaceuticalcommerce.com)
Conversely, the US-China trade tensions have opened avenues for Indian pharmaceutical companies to strengthen their foothold in the American market. India's pharmaceutical exports to the US surged by 74% in March 2025, indicating a shift in sourcing preferences. Ajanta Pharma can leverage this trend by emphasizing its compliance with stringent US regulatory standards and offering competitive pricing. (business-standard.com)
In the European Union, adherence to the Falsified Medicines Directive (FMD) is paramount. Indian exporters, including Ajanta, must ensure robust serialization and traceability measures to comply with these regulations. Non-compliance could result in restricted market access, underscoring the importance of investing in advanced tracking systems and quality assurance protocols.
Ajanta Pharma Limited — Regulatory Compliance & Quality Standards
The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the US FDA, WHO, and EU GMP setting stringent compliance benchmarks. India has made significant strides in this arena, surpassing the US in the number of FDA-registered generic manufacturing sites, boasting 752 FDA-approved facilities as of 2024. (business-standard.com) Ajanta Pharma's commitment to quality is evident in its adherence to these international standards, facilitating smoother market entry and bolstering its reputation among global stakeholders.
About Ajanta Pharma Limited
Ajanta Pharma Limited exports 37 products worth $116.1M. Beyond Dapagliflozin, top products include Artemether, Amlodipine, Clopidogrel, Rosuvastatin, Montelukast. View the complete Ajanta Pharma Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Dapagliflozin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Dapagliflozin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Ajanta Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 103 individual customs records matching Ajanta Pharma Limited exporting Dapagliflozin, covering 69 formulations to 4 countries via 8 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 113+ countries, 502+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Dapagliflozin Export Data from Ajanta Pharma Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Ajanta Pharma Limited's Dapagliflozin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Ajanta Pharma Limited
Full Company Profile →
37 products · $116.1M total trade · 17 categories
Dapagliflozin Stats
Company Overview
Top Products by Ajanta Pharma Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Ajanta Pharma Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Dapagliflozin. For current shipment-level data, contact TransData Nexus.